385 related articles for article (PubMed ID: 22185047)
1. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
[TBL] [Abstract][Full Text] [Related]
2. Effect of bilastine upon nasal obstruction.
Dávila I; Sastre J; Mullol J; Montoro J; Jáuregui I; Ferrer M; del Cuvillo A; Bartra J; Valero A
J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():2-8. PubMed ID: 22185044
[TBL] [Abstract][Full Text] [Related]
3. Safety profile of bilastine: 2nd generation H1-antihistamines.
Scaglione F
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729
[TBL] [Abstract][Full Text] [Related]
4. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
Janssens MM
Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
[TBL] [Abstract][Full Text] [Related]
5. Antihistamines in rhinoconjunctivitis.
Howarth P
Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
[TBL] [Abstract][Full Text] [Related]
6. Bilastine and quality of life.
Jáuregui I; Bartra J; del Cuvillo A; Dávila I; Ferrer M; Montoro J; Mullol J; Sastre J; Valero A
J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():16-23. PubMed ID: 22185046
[TBL] [Abstract][Full Text] [Related]
7. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.
Jáuregui I; García-Lirio E; Soriano AM; Gamboa PM; Antépara I
Expert Rev Clin Immunol; 2012 Jan; 8(1):33-41. PubMed ID: 22149338
[TBL] [Abstract][Full Text] [Related]
8. Clinical profile of astemizole. A survey of 50 double-blind trials.
Vanden Bussche G; Emanuel MB; Rombaut N
Ann Allergy; 1987 Mar; 58(3):184-8. PubMed ID: 2881507
[TBL] [Abstract][Full Text] [Related]
9. Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
Bousquet J; Ansótegui I; Canonica GW; Zuberbier T; Baena-Cagnani CE; Bachert C; Cruz AA; González SN; Kuna P; Morais-Almeida M; Mullol J; Ryan DP; Sánchez-Borges M; Valiente R; Church MK
Curr Med Res Opin; 2012 Jan; 28(1):131-9. PubMed ID: 22149770
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria.
Church MK
Expert Opin Drug Saf; 2011 Sep; 10(5):779-93. PubMed ID: 21831011
[TBL] [Abstract][Full Text] [Related]
11. Rapid symptom relief in rhinitis.
Bousquet J
Clin Exp Allergy; 1999 Mar; 29 Suppl 1():25-9. PubMed ID: 10209702
[TBL] [Abstract][Full Text] [Related]
12. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
Janssens MM; Vanden Bussche G
Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
[TBL] [Abstract][Full Text] [Related]
13. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Sastre J
Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
[TBL] [Abstract][Full Text] [Related]
14. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
[TBL] [Abstract][Full Text] [Related]
16. Focusing into new challenges in allergic rhinitis and urticaria. Introduction.
Valero Santiago AL
J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():1. PubMed ID: 22185043
[No Abstract] [Full Text] [Related]
17. [Rhinoconjunctivitis. Highly selective therapy using topical H1-blockers].
HNO; 1996 Mar; 44(3 Suppl):1-4. PubMed ID: 9022382
[No Abstract] [Full Text] [Related]
18. [A new H1-blocking antihistamine. Critical review of pharmacological and clinical studies].
Emmi L; Rossi O
Minerva Med; 1988 Mar; 79(3):219-27. PubMed ID: 2896316
[TBL] [Abstract][Full Text] [Related]
19. Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
Sologuren A; Viñas R; Cordón E; Riesgo SE; Del Mar Forés M; Senán MR; Fernández S; Labeaga L; Ruiz-Miján M
Allergy Asthma Proc; 2018 Jul; 39(4):299-304. PubMed ID: 29559031
[TBL] [Abstract][Full Text] [Related]
20. Bilastine: in allergic rhinitis and urticaria.
Carter NJ
Drugs; 2012 Jun; 72(9):1257-69. PubMed ID: 22686617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
